Literature DB >> 18714076

Prophylactic oophorectomy in premenopausal women and long-term health.

Lynne T Shuster1, Bobbie S Gostout, Brandon R Grossardt, Walter A Rocca.   

Abstract

OBJECTIVE: To review the data on long-term outcomes in women who underwent prophylactic bilateral oophorectomy, a common surgical procedure that has more than doubled in frequency since the 1960s. STUDY
DESIGN: Literature review of the published data on the consequences of prophylactic bilateral oophorectomy. Special emphasis was given to the Mayo Clinic Cohort Study of Oophorectomy and Aging. Main outcome measures Overall mortality, cardiovascular disease, cognitive impairment and dementia, parkinsonism, osteoporosis, psychological wellbeing and sexual function.
RESULTS: There is a growing body of evidence suggesting that the premature loss of ovarian function caused by bilateral oophorectomy performed before natural menopause is associated with several negative outcomes. In particular, studies have revealed an increased risk of premature death, cardiovascular disease, cognitive impairment or dementia, parkinsonism, osteoporosis and bone fractures, decline in psychological wellbeing and decline in sexual function. The effects involve different organs (e.g. heart, bone, or brain), and different functions within organs (e.g. cognitive, motor, or emotional brain functions). Estrogen treatment may prevent some but not all of these negative outcomes.
CONCLUSION: The potential adverse effects of prophylactic bilateral oophorectomy on heart health, neurological health, bone health and quality of life should be carefully weighed against its potential benefits for cancer risk reduction in women at average risk of ovarian cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18714076      PMCID: PMC2585770          DOI: 10.1258/mi.2008.008016

Source DB:  PubMed          Journal:  Menopause Int        ISSN: 1754-0453


  70 in total

Review 1.  Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.

Authors:  Raghvendra K Dubey; Bruno Imthurn; Matthias Barton; Edwin K Jackson
Journal:  Cardiovasc Res       Date:  2005-05-01       Impact factor: 10.787

Review 2.  Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: a meta-analysis.

Authors:  Femke Atsma; Marie-Louise E L Bartelink; Diederick E Grobbee; Yvonne T van der Schouw
Journal:  Menopause       Date:  2006 Mar-Apr       Impact factor: 2.953

3.  The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy.

Authors:  Joanna B Madalinska; Marc van Beurden; Eveline M A Bleiker; Heiddis B Valdimarsdottir; Judith Hollenstein; Leon F Massuger; Katja N Gaarenstroom; Marian J E Mourits; René H M Verheijen; Eleonora B L van Dorst; Hans van der Putten; Ko van der Velden; Henk Boonstra; Neil K Aaronson
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

4.  Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

Authors:  Walter A Rocca; Brandon R Grossardt; Mariza de Andrade; George D Malkasian; L Joseph Melton
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

5.  Quality of life among women undergoing hysterectomies.

Authors:  M K Rowe; D E Kanouse; B S Mittman; S J Bernstein
Journal:  Obstet Gynecol       Date:  1999-06       Impact factor: 7.661

6.  Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study.

Authors:  Barbara V Howard; Lewis Kuller; Robert Langer; JoAnn E Manson; Catherine Allen; Annlouise Assaf; Barbara B Cochrane; Joseph C Larson; Norman Lasser; Monique Rainford; Linda Van Horn; Marcia L Stefanick; Maurizio Trevisan
Journal:  Circulation       Date:  2005-03-21       Impact factor: 29.690

7.  Short-term transdermal estradiol therapy, cognition and depressive symptoms in healthy older women. A randomised placebo controlled pilot cross-over study.

Authors:  Rebekah Schiff; Christopher John Bulpitt; Keith A Wesnes; Chakravarthi Rajkumar
Journal:  Psychoneuroendocrinology       Date:  2004-12-02       Impact factor: 4.905

Review 8.  Elective oophorectomy for benign gynecological disorders.

Authors:  Donna Shoupe; William H Parker; Michael S Broder; Zhimei Liu; Cindy Farquhar; Jonathan S Berek
Journal:  Menopause       Date:  2007 May-Jun       Impact factor: 2.953

Review 9.  Current management strategies for ovarian cancer.

Authors:  Giovanni D Aletti; Mary M Gallenberg; William A Cliby; Aminah Jatoi; Lynn C Hartmann
Journal:  Mayo Clin Proc       Date:  2007-06       Impact factor: 7.616

Review 10.  Ovarian conservation at the time of hysterectomy for benign disease.

Authors:  William H Parker; Michael S Broder; Zhimei Liu; Donna Shoupe; Cindy Farquhar; Jonathan S Berek
Journal:  Clin Obstet Gynecol       Date:  2007-06       Impact factor: 2.190

View more
  67 in total

1.  Clinical pearls in women's health.

Authors:  Lynne T Shuster; John B Bundrick; Scott C Litin
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

2.  Ovarian cancer and the pelvic floor surgeon: the case for prophylactic bilateral salpingectomy during POP surgery.

Authors:  Peter L Dwyer
Journal:  Int Urogynecol J       Date:  2012-06       Impact factor: 2.894

3.  Reassessing hysterectomy.

Authors:  Elizabeth A Stewart; Lynne T Shuster; Walter A Rocca
Journal:  Minn Med       Date:  2012-03

4.  Fallopian tube removal: "stic-ing" it to ovarian cancer: what is the utility of prophylactic tubal removal?

Authors:  T J Herzog; H E Dinkelspiel
Journal:  Curr Oncol       Date:  2013-06       Impact factor: 3.677

Review 5.  Postmenopausal hormone therapy and cognition.

Authors:  Anna C McCarrey; Susan M Resnick
Journal:  Horm Behav       Date:  2015-04-30       Impact factor: 3.587

6.  Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Cathy D Schleck; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2016-02       Impact factor: 2.953

7.  Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers.

Authors:  Laura L Holman; Sue Friedman; Molly S Daniels; Charlotte C Sun; Karen H Lu
Journal:  Gynecol Oncol       Date:  2014-02-28       Impact factor: 5.482

8.  Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease.

Authors:  Virginia M Miller
Journal:  J Womens Health (Larchmt)       Date:  2014-12       Impact factor: 2.681

9.  Exercise for the management of side effects and quality of life among cancer survivors.

Authors:  Karen M Mustian; Lisa K Sprod; Oxana G Palesh; Luke J Peppone; Michelle C Janelsins; Supriya G Mohile; Jennifer Carroll
Journal:  Curr Sports Med Rep       Date:  2009 Nov-Dec       Impact factor: 1.733

Review 10.  Premature menopause and risk of neurological disease: basic mechanisms and clinical implications.

Authors:  Erin L Scott; Quan-Guang Zhang; Ratna K Vadlamudi; Darrell W Brann
Journal:  Mol Cell Endocrinol       Date:  2014-01-22       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.